Response to aflibercept after frequent re-treatment with bevacizumab or ranibizumab in eyes with neovascular AMD.
暂无分享,去创建一个
P. Rosenfeld | W. Feuer | Z. Yehoshua | G. Gregori | M. Thorell | Brian T. Kim | R. Nunes | Gene W Chen | D. Modi | Jyoti Dugar | R. Doshi | M. George | Matthew D Lowrance | Z. Nahas | Zohar Yehoshua | Giovanni Gregori